期刊文献+

ROR-γt、Foxp3在前列腺增生组织中的表达及意义 被引量:2

Expressions and significances of ROR-γt and Foxp3 in benign prostatic hyperplasia
下载PDF
导出
摘要 目的 探讨维甲酸相关孤儿受体(ROR-γt)、叉状/翼状螺旋转录因子(Foxp3)在前列腺增生(BPH)组织中的表达及临床意义。方法 选取2013年5~12月在本院行经尿道前列腺电切术(TURP)的BPH患者80例作为实验组(根据合并有和无组织学炎症分为实验组1和实验组2),另取健康男性18~27岁因外伤意外死亡法医及时尸体解剖并伦理委员会同意的5例前列腺组织作为对照组,迅速取出相应前列腺组织保存于液氮中,运用实时荧光定量PCR(QRT-PCR)检测ROR-γt、Foxp3mRNA的相对表达量,对两组研究对象的ROR-γt与Foxp3关系进行分析。结果 实验组1的ROR-γt mRNA含量明显高于对照组和实验组2(P〈0.05);实验组1的Foxp3mRNA含量明显低于对照组和实验组2(P〈0.05);ROR-γt、Foxp3mRNA在伴有组织炎症的前列腺增生组织与无组织学炎症的BPH组织中表达均有相关(r=0.623,P=0.002;r=-0.588,P=0.006)。结论 组织学炎症在BPH生组织中发挥重要作用,ROR-γt介导炎症反应、Foxp3抑制组织学炎症,其共同作用使组织局部微环境中Th17/Treg比例失衡,从而可能导致BPH的发生。 Objective To study the expressions and clinical significances of ROR-γt and Foxp3 in benign prostatic hyperplasia. Methods A total of 80 benign prostatic hyperplasia (BPH) cases treated with transurethral resection of the prostate (TURP) during May and Dec. 2013 were selected as the experimental group, which were subdivided into test group 1 (with inflammation) and test group 2 (without inflammation), and 5 cases of healthy male aged 18-27 years who died of trauma were involved as the control group. ROR-γt and Foxp3 mRNA relative expressions were detected with QRT-PCR, and their relationship was analyzed. Results ROR-γt mRNA content was significantly higher in test group 1 than in the control group and test group 2 (P〈0.05). Foxp 3 mRNA content was significantly lower in test group 1 than in the control group and experimental group 2 (P〈0.05). ROR-γt and Foxp 3 mRNA were associated with BPH with inflammation and BPH without inflammation (R = 0. 623, P = 0. 002 ; R =- 0. 588, P = 0. 006). Conclusion Inflammation plays an important role in BPH. ROR-γt mediates inflammation while Foxp3 inhibits inflammation, causing the imbalance of Th17/Treg ratio in the local microenvironment, which leads to the occurrence of prostate hyperplasia.
出处 《现代泌尿外科杂志》 CAS 2016年第10期755-758,共4页 Journal of Modern Urology
基金 四川省科技厅支撑计划(No.2014SZ0218) 四川省教育厅(No.14ZB0192) 南充市科技局(No.13A0049)
关键词 前列腺增生 ROR-γt FOXP3 TH17/TREG QRT-PCR benign prostatic hyperplasia ROR-γt Foxp3 Th17/Treg QRT-PCR
  • 相关文献

参考文献12

  • 1MANSOOREH ESLAMI, TAHERE KHAMECHIAN, TAHERE MAZOOCHI, et al. Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resec- tion of the prostate or prostatectomy[J]. Springer Plus, 2016, 5 (1) :1-6.
  • 2BREYER BN, HUANG WY, RABKIN CS, et al. Sexually transmitted infections, benign prostatic hyperplasia and lower u rinary tract symptom related outcomes= Results from the Pros- tate, Lung, Colorectal and Ovarian Cancer Screening Trial [J]. BJU Int, 2016,117(1) :274-277.
  • 3DE NUNZIO C,KRAMMER G, MARBERGER M, et al. Thecontroversial relationship between benign prostatic hyperplasia and prostate cancer the role of inflammation [J]. Eur Urol, 2011,60(1):106 117.
  • 4WANG MQ, GUO LP,DUAN F, et al. Prostatic arterial embo lization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia a comparative study of medium- and large volume prostates[J]. BJU Int, 2016,117 (1)402- 407.
  • 5GIANCARLO MARRA, PAUL STURCH, MARCO ODER DA, et al. Systematic review of lower urinary tract symptoms/ benign prostatic hyperplasia surgical treatments on men's ejacu latory function= Time for a bespoke approach'? [J]. Int J Urol, 2016, 23 (1):389 396.
  • 6KOSMACZEWSKA A, SWIERKOT J, CISZAK L, et al. The role o{ Thl, Th17, and Treg ceils in the pathogenesis o{ rheu matoid arthritis including anti-in{lammatory action of Thl cyto- kines [J]- Postepy Hig Med Dosw, 2011, 65:397 403.
  • 7KWON JK, HAN JH, CHOI HC, et al. Clinical significance o{ peripheral zone thickness in men with lower urinary tract symp toms/benign prostatic hyperplasia[J]. BJU Int, 2016, 117 (2) : 316 322.
  • 8RICK FG, SCHALLY AV, BLOCK NI., et al. LHRH antago nist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia[J]. Prostate, 2011,71(7) :736 747.
  • 9HIDEKI TAKESHITA, SHINGO MORIYAMA, YOSHIAKI ARAI, et al. Randomized crossover comparison of the short term efficacy and safety of single half-dose silodosin and tamsulosin hydrochoride in men with lower urinary tract symptoms seconda- ry to benign prostatic hyperplasia [ J ] Lower Urinary Tract Symptoms, 2016, 8 (1):170-184.
  • 10BALLERINI C, ALDINUCCI A, LUCCARINI I, et al. Antago- nism of histamine H4 receptors exacerbates clinical and patholog ical signs of experimental autoimmune encephalomyelitis [J]. Br J Pharmacol,2013, 170(1) :67-77.

同被引文献18

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部